Long-term health issues in ultraendurance runners: should we be concerned?
| Autor: | Volker Scheer, Daniel Rojas-Valverde |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Medicine (General) medicine.drug_class Cardiovascular health Cardiomyopathy Physical Therapy Sports Therapy and Rehabilitation cardiology prevention Human health R5-920 Internal medicine medicine Natriuretic peptide Orthopedics and Sports Medicine Health implications endurance business.industry assessing physiological demands of physical activity High intensity Atrial fibrillation medicine.disease adaptations of skeletal muscle to exercise and altered neuromuscular activity Editorial Cardiology athlete business |
| Zdroj: | BMJ Open Sport — Exercise Medicine BMJ Open Sport & Exercise Medicine, Vol 7, Iss 3 (2021) |
| ISSN: | 2055-7647 |
| Popis: | Participation in ultraendurance running (UER) has increased considerably, especially over the past 20 years the participation worldwide has risen from 5000 in 2000 to 300 000 in 2017.1 It includes running distances over 42.195 km, timed events over 6 hours duration or multiday or multistage events. Additionally, there is also an important increase in youth UER participation under the ages of 19 years.2 The long-term impact on human health due to extreme exercise bouts, such as UER, is largely unknown. Research in UER has primarily focused on acute physiological, biochemical and medical alterations immediately or shortly after UER events but long-term health effects have rarely been investigated. UER is considered one of the sports that causes the most functional and structural damage due to its high intensity and volume.3 UER usually affects anti-inflammatory and proinflammatory responses leading to several acute preclinical and clinical issues.4 In this editorial, we aim to discuss some of the potential long-term health implications of UER based on central body systems. UER may have negative effects on cardiovascular health such as acute alterations in biomarkers of cardiac damage (eg, cardiac troponin-I, ventricular natriuretic peptide)5 and potential long-term cardiac issues such as ventricular dysfunction, myocardial remodelling, atrial fibrillation, myocardial fibrosis or right ventricle exercise-induced cardiomyopathy later in life. However, the risk is low and usually depends on a pre-existing cardiovascular condition and there is a U-shaped relationship of lifetime-accumulated high-intensity endurance training.6 … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|